Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

NCT05425992 | Recruiting DMC

• 2 other identifiers: 21-4238.ccNCI-2022-04061
• Study Type: observational
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.

Conditions

Leukemia; Non Hodgkin Lymphoma

Keywords

Spanish-speaking

Outcome Measures

Primary Outcomes (5)

• Determine a baseline level of Spanish speaking patient satisfaction of care

  Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers.

  12 months

• Determine a baseline level of Spanish Speaking family satisfaction of care

  Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers.

  12 months

• Determine effects of language barrier on Spanish speaking patient needs

  Understand the patient experience using qualitative interview of Spanish speaking patients and families. Determine satisfaction based on open-ended question to determine a list or pattern of common patient needs.

  12 months

• Determine the effect of language barrier on barriers to patient care

  Understand the patient experience using qualitative interview of Spanish speaking patients and families. Determine satisfaction based on open-ended question to determine a list or pattern of common barriers to patient care.

  12 months

• Effect of language barrier on efficiency of access to care

  Understand the patient experience using qualitative interview of Spanish speaking patients and families. Determine satisfaction based on open-ended question to determine how quickly patient was able to receive care.

  12 months

Secondary Outcomes (6)

• Determine patient interest in home telemedicine support program

  12 months

• Determine patient interest in home telemedicine support program after discharge

  12 months

• Determine Spanish speaking patient interest in telemedical check-ins during intensive phases of therapy

  12 months

• Determine Spanish speaking patient interest in medication assistance during intensive phases of therapy

  12 months

• Determine Spanish speaking patient interest in medical check-ins during maintenance

  12 months

Study Arms (1)

Patients treated in CCBD

Patients who are currently receiving therapy at the Center for Cancer and Blood Disorders

Other: Interview

Interventions

Interview OTHER

Patient/parent dyads expressing interest will be interviewed by a bilingual Spanish certified provider via televideo with as needed interpreter support. Interviews will be audio recorded for review and translation purposes and then will be destroyed. Interview format will be supportive and information seeking only with reassurance that purpose is for care improvement and that all answers will be evaluated without association to patient name. Interviews will then be translated and reviewed by the PI for themes regarding perceived clinic successes and perceived clinic barriers in communication or care.

Patients treated in CCBD

Eligibility Criteria

• Age: Up to 22 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Patients eligible for enrollment are identified from EPIC electronic medical record with notification for newly diagnosed families of Spanish language preference.

You may qualify if:

• to 22 years of age
• Diagnosis of leukemia or non-Hodgkin lymphoma
• Spanish as preferred language for patient, parent or guardian
• Received or receiving care at the Center for Cancer and Blood Disorders (CCBD)

You may not qualify if:

• Patients without oncologic diagnosis
• Patients with parents whose language preference is English
• Patients who received care solely outside of the CCBD

Sponsors & Collaborators

• University of Colorado, Denver: lead
• Children's Hospital Colorado: collaborator

Study Sites (1)

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

RECRUITING

MeSH Terms

Conditions

Leukemia; Lymphoma, Non-Hodgkin

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoma; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Ashley Rogers

  Children's Hospital Colorado

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Wendy Moore

CONTACT

1-720-777-6353; wendy.moore@childrenscolorado.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 15, 2022
• First Posted: June 21, 2022
• Study Start: March 17, 2022
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2027
• Last Updated: February 5, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)